Related references
Note: Only part of the references are listed.Sorafenib Ameliorates Renal Fibrosis through Inhibition of TGF-β-Induced Epithelial-Mesenchymal Transition
Lining Jia et al.
PLOS ONE (2015)
Smad7 inhibits AngII-mediated hypertensive nephropathy in a mouse model of hypertension
Guan-Xian Liu et al.
CLINICAL SCIENCE (2014)
Endothelin and endothelin antagonists in chronic kidney disease
Donald E. Kohan et al.
KIDNEY INTERNATIONAL (2014)
Chaihuang-Yishen Granule Inhibits Diabetic Kidney Disease in Rats through Blocking TGF-β/Smad3 Signaling
Ting Ting Zhao et al.
PLOS ONE (2014)
Astragaloside IV Ameliorates Renal Fibrosis via the Inhibition of Mitogen-Activated Protein Kinases and Antiapoptosis In Vivo and In Vitro
Weijia Xu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
NMR Solution Structure Study of the Representative Component Hydroxysafflor Yellow A and Other Quinochalcone C-Glycosides from Carthamus tinctorius
Zi-Ming Feng et al.
JOURNAL OF NATURAL PRODUCTS (2013)
Chronic kidney disease: global dimension and perspectives
Vivekanand Jha et al.
LANCET (2013)
Activation of PPARγ is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress
C. Y. Wang et al.
PHYTOMEDICINE (2013)
Curcumin Inhibits Transforming Growth Factor-beta 1-Induced EMT via PPAR gamma Pathway, Not Smad Pathway in Renal Tubular Epithelial Cells
Rui Li et al.
PLOS ONE (2013)
Prevalence of chronic kidney disease in China: a cross-sectional survey
Luxia Zhang et al.
LANCET (2012)
Inhibitory Effect of Safflor Yellow on Pulmonary Fibrosis
Lin Wang et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential
Hai Yong Chen et al.
DIABETES (2011)
Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis
Yingbo Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Diverse Roles of TGF-beta/Smads in Renal Fibrosis and Inflammation
Hui Yao Lan
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Delayed Administration of Suramin Attenuates the Progression of Renal Fibrosis in Obstructive Nephropathy
Na Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases
Jeffrey L. Barnes et al.
KIDNEY INTERNATIONAL (2011)
Cellular and molecular mechanisms of renal fibrosis
Youhua Liu
NATURE REVIEWS NEPHROLOGY (2011)
Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-β1 signal transduction pathway in vivo and in vitro
Qing-Lan Wang et al.
BMC CELL BIOLOGY (2010)
New Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis
Youhua Liu
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
HSP72 Inhibits Smad3 Activation and Nuclear Trans location in Renal Epithelial-to-Mesenchymal Transition
Yi Zhou et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Endothelial-Myofibroblast Transition Contributes to the Early Development of Diabetic Renal Interstitial Fibrosis in Streptozotocin-Induced Diabetic Mice
Jinhua Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
In vitro anti-fibrotic activities of herbal compounds and herbs
Qin Hu et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Safflower extract: A novel renal fibrosis antagonist that functions by suppressing autocrine TGF-Beta
Yu-Lin Yang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Compound Astragalus and Salvia miltiorrhiza Extract exerts anti-fibrosis by mediating TGF-β/Smad signaling in myofibroblasts
Yan Yang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2008)
Fibroblasts in Kidney Fibrosis Emerge via Endothelial-to-Mesenchymal Transition
Elisabeth M. Zeisberg et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
TGF-β in renal injury and disease
Erwin P. Bottinger
SEMINARS IN NEPHROLOGY (2007)
The role of tubular epithelial-mesenchymal transition in progressive kidney disease
W. C. Burns et al.
CELLS TISSUES ORGANS (2007)
TGF-β1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation
NG Docherty et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention
YH Liu
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy
GQ Zhang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy
JW Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2003)
Targeted disruption of TGF-beta 1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction
M Sato et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Interstitial expression of α-SMA:: an early marker of chronic renal allograft dysfunction
C Badid et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
TGF-β signaling in renal disease
EP Böttinger et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis
JW Yang et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
The role of tubulointerstitial injury in chronic renal failure
GJ Becker et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2000)
Share Paper
